Skip to main content

Table 1 Baseline characteristics of participants in longitudinal study.

From: Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study

Variable Q1 LAP Q2 LAP Q3 LAP Q4 LAP P for trend
Men      
LAP 0.62-21.96 21.97-40.93 40.94-68.51 68.52-570.26  
Age 33.1(15.4) 43.3(13.5) 45.0(13.3) 44.7(12.6) <0.001
FHx of DM 67(20.1) 75(22.5) 94(28.2) 97(29.1) = 0.002
DM 8(9.1) 13(14.8) 29(33.0) 38(43.2) <0.001
IFG 19(9.) 747(24.0) 48(24.5) 82(41.8) <0.001
IGT 14(0.9) 34(21.9) 44(28.4) 63(40.6) <0.001
SBP 114.3(16.6) 117.3(14.9) 122.6(18.4) 124.7(16.6) <0.001
DBP 73.3(9.8) 76.8(9.3) 80.4(10.4) 82.1(10.1) <0.001
MAP 87.3(10.7) 90.4(10.2) 94.4(12.0) 96.3(11.2) <0.001
BMI 21.6(2.4) 25.0(2.3) 27.1(2.7) 29.0(3.4) <0.001
WHpR 84.0(4.8) 90.3(4.7) 94.3(5.0) 96.7(5.1) <0.001
WHtR 44.5(4.1) 50.1(3.9) 54.6(4.2) 57.7(5.1) <0.001
FPG 4.9(0.5) 5.1(0.5) 5.1(0.5) 5.2(0.6) <0.001
2h-PCPG 5.0(1.4) 5.6(1.6) 5.9(1.7) 6.2(1.8) <0.001
Women      
LAP 0.56-22.26 22.27-42.90 42.91-73.98 73.99-620.39  
Age 31.2(8.5) 39.6(11.5) 43.9(11.9) 50.0(11.1) <0.001
FHx of DM 103(19.4) 135(25.4) 140(26.4) 153(28.8) <0.001
DM 5(3.5) 19(13.3) 48(33.6) 71(49.7) <0.001
IFG 14(6.20) 43(19.1) 72(32.0) 96(42.7) <0.001
IGT 14(5.1) 42(15.2) 86(31.2) 134(48.6) <0.001
SBP 106.8(10.9) 114.3(16.1) 120.2(16.7) 125.7(19.3) <0.001
DBP 71.3(8.2) 76.4(9.5) 79.3(9.4) 82.2(9.5) <0.001
MAP 83.1(8.2) 89.0(10.8) 92.9(10.8) 96.7(11.9) <0.001
BMI 23.0(3.2) 26.8(3.4) 29.2(3.7) 31.5(4.3) <0.001
WHpR 75.6(5.1) 81.8(6.2) 86.1(6.1) 89.5(6.5) <0.001
WHtR 46.4(4.5) 53.8(5.2) 58.8(5.3) 63.5(6.2) <0.001
FPG 4.7(0.4) 4.9(0.5) 5.1(0.5) 5.2(0.6) <0.001
2h-PCPG 5.2(1.2) 5.9(1.4) 6.4(1.5) 6.9(1.6) <0.001
  1. All continuous variables are represented as mean (SD) and all dichotomous variables as number (percent). P values for trends were obtained from linear or logistic regression models for continuously- and binary-distributed variables, respectively.
  2. BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; FHx, family history; PFG, fasting plasma glucose; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LAP, lipid accumulation product; MAP, mean arterial pressure; Q, quartile; SBP, systolic blood pressure; 2 h-PCGP, 2-hour post challenge plasma glucose; WHpR waist to hip ratio; WHtR, waist to height ratio.